Tukysa 150 mg Tablet contains Tucatinib, a HER2-targeted tyrosine kinase inhibitor (TKI) used for treating HER2-positive breast cancer, including cases that have spread to the brain.

Uses:

✔ HER2-Positive Metastatic Breast Cancer – Used in combination with trastuzumab and capecitabine for advanced or metastatic cases.
✔ Brain Metastases – Effective in treating HER2-positive breast cancer that has spread to the brain.

How Tukysa Works:

Tucatinib selectively inhibits the HER2 receptor, blocking cancer cell growth and proliferation, helping slow tumor progression.

Common Side Effects:

🔹 Diarrhea
🔹 Nausea & vomiting
🔹 Fatigue
🔹 Liver enzyme elevation
🔹 Decreased appetite

Serious Side Effects (Seek Medical Help):

⚠️ Severe diarrhea & dehydration
⚠️ Liver toxicity (yellowing of skin/eyes, dark urine)
⚠️ Heart complications (irregular heartbeat, chest pain)

Precautions:

⚡ Pregnancy & Breastfeeding: Not recommended due to potential fetal harm.
⚡ Liver Function Monitoring: Regular tests needed for patients with liver issues.
⚡ Drug Interactions: Avoid strong CYP3A4 inducers like rifampin and certain antifungals.

FAQs:

1. How is Tukysa 150 mg taken?
It is taken orally, twice daily, in combination with trastuzumab and capecitabine.

2. How long does it take for Tukysa to show results?
Response time varies, but improvement is typically seen within the first few cycles of treatment.

3. Can Tukysa be used alone?
No, it is always used in combination with trastuzumab and capecitabine for best results.

4. Does Tukysa affect brain metastases?
Yes, it has shown effectiveness in treating HER2-positive brain metastases.

5. Where can I buy Tukysa 150 mg Tablet online?
Order from Milan Medicals for authentic products, competitive pricing, and worldwide shipping.

References:

🔗 https://en.wikipedia.org/wiki/Tucatinib
🔗 https://my.clevelandclinic.org/health/drugs/21372-tucatinib-tablets